Seroprevalence of Pertussis Among Children and Adolescents in Croatia

Immunogenicity, Vaccine Clinical Trial

Official title:
Seroprevalence of Pertussis Antibodies Among Children and Adolescents in Croatia - Investigation of the Waning Vaccine-induced Immunity in Children and Adolescents

Status Recruiting

Clinical Trial Summary

Pertussis is a vaccine preventable disease caused by Bordetella pertussis. Older children and adolescents with pertussis continue to be a significant source of infection for incompletely vaccinated infants who are in harm for developing severe disease. The primary objective of our study is to estimate the duration of protection elicited by the current vaccination schedule against pertussis in Croatia.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04725669
Study type	Interventional
Source	University Hospital for Infectious Diseases, Croatia
Contact	Goran Tešovic
Phone	+385914012605
Email	gtesovic@bfm.hr
Status	Recruiting
Phase	N/A
Start date	January 15, 2021
Completion date	September 8, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05298800` - Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23	Phase 4
Completed	`NCT04756817` - Immunogenicity of the BNT162b2 Covid-19 Vaccine in Elderly People Aged 85 and Older in Greece
Recruiting	`NCT03405805` - Immunological Memory Against Pneumococcus Induced by 3 Infant PCV 13 Vaccination Schedules	N/A
Completed	`NCT05104359` - COVID-19 Quantitative Antibody Titers & Booster Vaccinations
Completed	`NCT05372575` - A COHORT STUDY TO EVALUATE IMMUNOGENICITY FOR CHINESE CHILDREN AT THE TIME OF CLINICAL PNEUMONIA DIAGNOSIS	N/A